Strides Shasun Archives - Express Pharma

Strides Shasun receives USFDA tentative approval for Roflumilast tablets

Strides Shasun to divest UK arm for GBP 25 m

Strides Shasun to acquire three brands of Moberg Pharma

Strides Shasun biotech arm receives $8.49 million investment from GMS Holdings

Sun completes sale of two Ranbaxy divisions to Strides Shasun

Strides Shasun gets CCI nod to buy Sun Pharma’s two divisions

Strides Shasun receives DCG(I) nod for Sofosbuvir

Strides Shasun opens QIP, floor price at Rs 1,344.78 per scrip